Conmed (CNMD) Other Non Operating Income (2010 - 2026)
Conmed's (CNMD) quarterly Other Non Operating Income came in at $2.8 million in Q2 2026, up 775.84% on a YoY basis from $322548.5 in Q2 2025, and up 775.84% quarter-over-quarter from -$418000.0 in Q2 2025.
Powered by 
Analysis
Conmed (CNMD) Other Non Operating Income (2010 - 2026) Analysis & Trends
Conmed (CNMD) has reported Other Non Operating Income for 7 consecutive years, with $2.8 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other Non Operating Income rose 775.84% year-over-year to $2.8 million; the trailing twelve-month figure through Jun 2026 stood at $21.2 million (up 15.38% YoY), and the FY2025 full-year result was -$3.4 million, down 37.53% from the prior year.
- Other Non Operating Income climbed to $2.8 million in Q2 2026 per CNMD's latest filing, from -$418000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $2.8 million in Q2 2026 and bottomed at -$418000.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Conmed | 1.42 Bn | 1.38 Bn | 197.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.83 Mn |
| Jun 30, 2025 | -418,000.00 |
| Dec 31, 2014 | 18.78 Mn |
| Dec 31, 2013 | -17.91 Mn |
| Mar 31, 2013 | -300,000.00 |
| Dec 31, 2012 | -1.39 Mn |
| Dec 31, 2011 | 20.25 Mn |
| Jun 30, 2010 | 79,000.00 |